Replies to post #102243 on Biotech Values

[DewDiligence]

Do you think the FDA will consider the IL-28B variant when reviewing the NDA for boceprevir and telaprevir?

No—I think the FDA will ask VRTX and MRK to investigate the relevance of IL-28B variants as part of the companies’ post-marketing commitments.